BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6308174)

  • 1. Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.
    Kimberlin RH; Walker CA; Millson GC; Taylor DM; Robertson PA; Tomlinson AH; Dickinson AG
    J Neurol Sci; 1983 Jun; 59(3):355-69. PubMed ID: 6308174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid chemical decontamination of infectious CJD and scrapie particles parallels treatments known to disrupt microbes and biofilms.
    Botsios S; Tittman S; Manuelidis L
    Virulence; 2015; 6(8):787-801. PubMed ID: 26556670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of scrapie agent after exposure to sodium dodecyl sulphate and heat.
    Taylor DM; Fernie K; McConnell I; Steele PJ
    Vet Microbiol; 1999 Jun; 67(1):13-6. PubMed ID: 10392773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease.
    Taylor DM
    J Hosp Infect; 1991 Jun; 18 Suppl A():141-6. PubMed ID: 1679777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the reduction of Creutzfeldt-Jakob disease prion seeding activity by steam sterilization support the use of validated 134°C programmes.
    Schwenke KA; Wagenführ K; Thanheiser M; Beekes M
    J Hosp Infect; 2023 Feb; 132():125-132. PubMed ID: 36216171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie.
    Taylor DM; Fraser H; McConnell I; Brown DA; Brown KL; Lamza KA; Smith GR
    Arch Virol; 1994; 139(3-4):313-26. PubMed ID: 7832638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of a novel agent possessing resistance to moist heat and disinfectants: parallels with Creutzfeldt-Jakob agent.
    Dyas AC; Burdon DW
    J Hosp Infect; 1990 Apr; 15(3):265-72. PubMed ID: 1971633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectivity of scrapie prions bound to a stainless steel surface.
    Zobeley E; Flechsig E; Cozzio A; Enari M; Weissmann C
    Mol Med; 1999 Apr; 5(4):240-3. PubMed ID: 10448646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scrapie of sheep and Creutzfeldt-Jakob disease in Iceland].
    Georgsson G; Olafsson E; Gudmundsson G
    Laeknabladid; 2008 Jul; 94(7-8):541-8. PubMed ID: 18591729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of scrapie and Creutzfeldt-Jakob disease in mice.
    Kingsbury DT; Kasper KC; Stites DP; Watson JD; Hogan RN; Prusiner SB
    J Immunol; 1983 Jul; 131(1):491-6. PubMed ID: 6408182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of RML scrapie agent to a sodium percarbonate-based product and sodium dodecyl sulfate renders PrPSc protease sensitive but does not eliminate infectivity.
    Smith JD; Nicholson EM; Foster GH; Greenlee JJ
    BMC Vet Res; 2013 Jan; 9():8. PubMed ID: 23311930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleaning, disinfection and sterilization of surface prion contamination.
    McDonnell G; Dehen C; Perrin A; Thomas V; Igel-Egalon A; Burke PA; Deslys JP; Comoy E
    J Hosp Infect; 2013 Dec; 85(4):268-73. PubMed ID: 24074640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization.
    Rutala WA; Weber DJ
    Clin Infect Dis; 2001 May; 32(9):1348-56. PubMed ID: 11303271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the effects of several chemical and physical treatments on the activity of protease resistance and infectivity of scrapie strain 263K.
    Yao HL; Han J; Gao JM; Zhang J; Zhang BY; Guo YJ; Nie K; Gao C; Wang XF; Dong XP
    J Vet Med B Infect Dis Vet Public Health; 2005 Dec; 52(10):437-43. PubMed ID: 16364019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease.
    Walker AS; Inderlied CB; Kingsbury DT
    Am J Public Health; 1983 Jun; 73(6):661-5. PubMed ID: 6342430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease).
    Gajdusek DC; Gibbs CJ; Asher DM; Brown P; Diwan A; Hoffman P; Nemo G; Rohwer R; White L
    N Engl J Med; 1977 Dec; 297(23):1253-8. PubMed ID: 335248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.
    Manuelidis L; Sklaviadis T; Akowitz A; Fritch W
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5124-8. PubMed ID: 7761460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions--infectious pathogens causing the spongiform encephalopathies.
    Prusiner SB; Kingsbury DT
    CRC Crit Rev Clin Neurobiol; 1985; 1(3):181-200. PubMed ID: 3915974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen.
    Tateishi J; Tashima T; Kitamoto T
    Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.